| Capitol Spine And Rehabilitation | |
|
429 E Airport Ave, Suite 1, Baton Rouge, LA 70806-4844 | |
| (226) 926-1900 | |
| (225) 926-1901 |
| Full Name | Capitol Spine And Rehabilitation |
|---|---|
| Type | Facility |
| Speciality | Chiropractor |
| Location | 429 E Airport Ave, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366692535 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 1307 (Louisiana) | Secondary |
| 111N00000X | Chiropractor | 1441 (Louisiana) | Primary |
| Provider Name | Latresia G Broussard-bell |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1679648109 PECOS PAC ID: 9436165701 Enrollment ID: I20060224000147 |
News Archive
A UTA researcher will use a National Institutes of Health grant to build new imaging technology that will study blood vessel function in patients with heart failure that could lead to quicker diagnosis and life-saving treatment.
New research suggests that following a high-fat diet during lactation-;regardless of diet during pregnancy-;alters RNA activity in breast milk. The changes in genetic material may increase the risk of metabolic disorders such as type 2 diabetes in offspring. The article is published ahead of print in Physiological Genomics.
Researchers at the University of California, San Diego School of Medicine have discovered that a multi-tasking protein called FoxO1 has another important but previously unknown function: It directly interacts with macrophages, promoting an inflammatory response that can lead to insulin resistance and diabetes. Contrarily, it also generates a negative feedback loop that can limit damage from excessive inflammation.
In the fight against obesity, bariatric surgery is currently the most effective treatment; however, only 1 to 2 percent of qualified patients receive this surgery due to limited access, patient choice, associated risks and the high costs. A novel treatment method - endoscopic sleeve gastroplasty - might offer a new solution for obese patients.
Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces that the first patients have been dosed in the United States in a global Phase 3 clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML). The first patient was dosed on July 22, 2014.
› Verified 8 days ago
| Provider Name | Gerald O Bell |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1255489423 PECOS PAC ID: 8123159613 Enrollment ID: I20100628000392 |
News Archive
A UTA researcher will use a National Institutes of Health grant to build new imaging technology that will study blood vessel function in patients with heart failure that could lead to quicker diagnosis and life-saving treatment.
New research suggests that following a high-fat diet during lactation-;regardless of diet during pregnancy-;alters RNA activity in breast milk. The changes in genetic material may increase the risk of metabolic disorders such as type 2 diabetes in offspring. The article is published ahead of print in Physiological Genomics.
Researchers at the University of California, San Diego School of Medicine have discovered that a multi-tasking protein called FoxO1 has another important but previously unknown function: It directly interacts with macrophages, promoting an inflammatory response that can lead to insulin resistance and diabetes. Contrarily, it also generates a negative feedback loop that can limit damage from excessive inflammation.
In the fight against obesity, bariatric surgery is currently the most effective treatment; however, only 1 to 2 percent of qualified patients receive this surgery due to limited access, patient choice, associated risks and the high costs. A novel treatment method - endoscopic sleeve gastroplasty - might offer a new solution for obese patients.
Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces that the first patients have been dosed in the United States in a global Phase 3 clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML). The first patient was dosed on July 22, 2014.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Capitol Spine And Rehabilitation 429 E Airport Ave, Suite 1, Baton Rouge, LA 70806-4844 Ph: (226) 926-1900 | Capitol Spine And Rehabilitation 429 E Airport Ave, Suite 1, Baton Rouge, LA 70806-4844 Ph: (226) 926-1900 |
News Archive
A UTA researcher will use a National Institutes of Health grant to build new imaging technology that will study blood vessel function in patients with heart failure that could lead to quicker diagnosis and life-saving treatment.
New research suggests that following a high-fat diet during lactation-;regardless of diet during pregnancy-;alters RNA activity in breast milk. The changes in genetic material may increase the risk of metabolic disorders such as type 2 diabetes in offspring. The article is published ahead of print in Physiological Genomics.
Researchers at the University of California, San Diego School of Medicine have discovered that a multi-tasking protein called FoxO1 has another important but previously unknown function: It directly interacts with macrophages, promoting an inflammatory response that can lead to insulin resistance and diabetes. Contrarily, it also generates a negative feedback loop that can limit damage from excessive inflammation.
In the fight against obesity, bariatric surgery is currently the most effective treatment; however, only 1 to 2 percent of qualified patients receive this surgery due to limited access, patient choice, associated risks and the high costs. A novel treatment method - endoscopic sleeve gastroplasty - might offer a new solution for obese patients.
Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces that the first patients have been dosed in the United States in a global Phase 3 clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML). The first patient was dosed on July 22, 2014.
› Verified 8 days ago
Back In Action Rehab Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 5145 Bluebonnet Blvd, Baton Rouge, LA 70809 Phone: 225-408-1422 Fax: 225-408-1462 | |
Midcity Imaging Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 660 N Foster Dr, A101, Baton Rouge, LA 70806 Phone: 225-201-0901 Fax: 225-201-0955 | |
Manipulation Under Anesthesia Musculoskeletal Group Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 429 E Airport Ave, Suite 1, Baton Rouge, LA 70806 Phone: 225-926-1900 Fax: 225-926-1901 | |
Chiropractic Sports And Injury Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 6160 Perkins Rd Ste 130, Baton Rouge, LA 70808 Phone: 225-766-3031 Fax: 225-767-0045 | |
Dr. Patrick Anthony Martello, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 7707 Old Hammond Hwy, Ste A, Baton Rouge, LA 70809 Phone: 225-927-6921 Fax: 225-927-6925 | |
Dr. Vanessa Jayne Aucoin, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1857 Wooddale Blvd, Baton Rouge, LA 70806 Phone: 225-927-8160 Fax: 225-927-7751 | |
Dr. Steven F. Angle, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 311 E Airport Ave, Baton Rouge, LA 70806 Phone: 225-926-2273 Fax: 225-926-2273 |